This is a synthetic peptide designed for use in combination with anti-CDK2 antibody (Catalog #: AVARP01008_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Phospho-cdk2 (Thr160) probably involved in the control of the cell cycle. It interacts with cyclins A, D, or E. Activity of cdk2 is maximal during S phase and G2.
Alias Symbols: p33(CDK2)
Protein Interaction Partner: BRCA1,CCNA2,CCNA2,CCNA2,RB1,SMAD2,SMAD3,MITF,BCL2,BRCA1,BRCA2,CCNA1,CCNA2,CCNB2,CCNB3,CCNE1,CCNE2,CCNH,CCNK,CDC25A,CDC37,CDC6,CDC7,CDK2,CDK20,CDK2AP1,CDK7,CDKN1A,CDKN1B,CDKN3,CDT1,CDX2,CEBPA,CHAF1A,CHAF1B,CKS1B,CNOT7,COIL,CP110,EP300,FEN1,FOXM1,FZR1,HIRA,HIST1H1B,ID2,ID3,LYN,MCM3,MCM4,MNDA,MYBL2,MYOD1,NFYA,NPDC1,NPM1,ORC1L,ORC2L,PCNA,POLA1,POLD1,POLD2,POLL,PPM1B,PRC1,PRKAR1A,PRKCH,PTHLH,PTMA,PTPN2,RB1,RBL1,RBL2,SKP2,SMAD3,SPDYA,TP53,TP73,TSPYL2,UBE2A,UBTF,UHRF2,WEE1,BCCIP,BIRC5,BRCA1,CASP4,CCNA1,CCNA1,CCNA2,CCNA2,CCNA2,CCNA2,CCNA2,CCNB1,CCNB3,CCNE1,CCNE2,CDC25A,CDC25B,CDC5L,CDC6,CDK15,CDK2AP1,CDK6,CDK7,CDKN1A,CDKN1A,CDKN1A,CDKN1A,CDKN1A,CDKN1B,CDKN1B,CDKN1B,CDKN1B,CDKN3,CEBPA,CKS1B,CNOT7,E2F1,EPB41,FAM113A,FBL,FEN1,HIST1H1B,IME2,INCA1,LYN,MCM4,MS4A3,MYBL2,Mybl2,NAA25,NEDD8,NPDC1,OGT,ORC1L,ORC2L,PCNA,POLA1,PPM1B,PPP2CA,PRKCH,PTP4A3,RADIL,RB1,RBL1,RBL2,RBM4,REL,RRN3,SKP2,SORT1,SPDYA,TP53,TSC22D1,UBE2A,UBE2M,VHL,WDR8,XRCC6,tax